Press Releases Autonomix Medical, Inc.

Equities

AMIX

US05330T1060

Delayed Nasdaq Other stock markets 03:51:57 2024-05-20 pm EDT			5-day change	1st Jan Change
2.31 ^USD	-7.60%		-12.55%	0.00%

Apr. 25	Autonomix Enters into Agreement with Noisefigure Research, Inc. to Develop Next Generation of Its Proprietary Microchip	CI
Apr. 16	Autonomix Medical Secures US Patent for Catheter-Based Technology to Treat Cancer-Related Pain	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series	May. 14	AQ
Autonomix Enters into Agreement with NoiseFigure Research, Inc. to Develop Next Generation of its Proprietary Microchip	Apr. 25	AQ
Autonomix to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar	Apr. 24	AQ
Autonomix Medical Inc Covered in Benzinga Article Highlighting Innovative Nerve Treatment Tech	Apr. 16	AQ
Autonomix Announces Issuance of U.S. Patent Covering Proprietary Catheter-Based Technology for the Treatment of Cancer Related Pain	Apr. 16	AQ
Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment Technology	Apr. 15	AQ
Autonomix Announces Positive Findings from Preclinical Study Demonstrating Potential to Improve Renal Denervation	Apr. 09	AQ
Autonomix to Participate in the Virtual Investor Lunch Break: The Team Behind the AMIX Ticker	Apr. 08	AQ
Autonomix to Present at the MedInvest Biotech & Pharma Investor Conference	Mar. 27	AQ
Autonomix (NASDAQ: AMIX) to Present at the Benzinga Virtual Healthcare Summit 2024	Mar. 20	AQ
Autonomix Appoints Jennifer Cook as Chief Business Officer	Mar. 19	AQ
Autonomix Completes First Three Patient Procedures in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market	Mar. 14	AQ
Autonomix Enrolls First Patients in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market	Mar. 06	AQ
Autonomix Signs Key Clinical Agreements in Preparation to Begin March 2024 Human Clinical Trial	Feb. 29	AQ
Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Lunch Break: The Autonomix Opportunity	Feb. 23	AQ
Autonomix Secures Principal Investigators and Completes Clinical Training for First Human Study	Feb. 22	AQ
Autonomix Begins Human POC Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market	Feb. 16	AQ
Autonomix Medical, Inc. Reports Third Quarter FY2024 Financial Results and Reiterates Upcoming Key Milestones	Feb. 14	AQ
Autonomix Medical, Inc. Receives Ethics Committee Authorization for Proof-of-Concept Human Clinical Study Evaluating Proprietary Ablation Technology for Treatment of Pancreatic Cancer Pain	Feb. 06	AQ
Autonomix Medical, Inc. (NASDAQ: AMIX) to Present at the Virtual Investor New to the Street Event	Feb. 01	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Autonomix Medical, Inc.

Equities

AMIX

US05330T1060

Press Releases

Filters